Format

Send to

Choose Destination
See comment in PubMed Commons below
PLoS One. 2011 Mar 30;6(3):e18257. doi: 10.1371/journal.pone.0018257.

A melanoma molecular disease model.

Author information

1
CollabRx Inc, Palo Alto, California, United States of America.

Abstract

While advanced melanoma remains one of the most challenging cancers, recent developments in our understanding of the molecular drivers of this disease have uncovered exciting opportunities to guide personalized therapeutic decisions. Genetic analyses of melanoma have uncovered several key molecular pathways that are involved in disease onset and progression, as well as prognosis. These advances now make it possible to create a "Molecular Disease Model" (MDM) for melanoma that classifies individual tumors into molecular subtypes (in contrast to traditional histological subtypes), with proposed treatment guidelines for each subtype including specific assays, drugs, and clinical trials. This paper describes such a Melanoma Molecular Disease Model reflecting the latest scientific, clinical, and technological advances.

PMID:
21479172
PMCID:
PMC3068163
DOI:
10.1371/journal.pone.0018257
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Public Library of Science Icon for PubMed Central
    Loading ...
    Support Center